Insights On CONTRACT PHARMA MANUFACTURING
-
You Need A Gap Analysis Before Outsourcing
5/15/2024
Vincent Kosewski, VP at Kala Pharmaceuticals, believes there’s a gap when it comes to biotechs performing the necessary gap analysis before initiating outsourcing activities.
-
Outsourcing Not Plug-And-Play
5/15/2024
Joanne Beck, Chief Technology Officer, Aerium Therapeutics, starts our Outsourced Pharma Live with a caution: Working with CDMOs is less like a plug-and-play model, and more like a custom-fit set of activities.
-
Tackling Antimicrobial Resistance
5/14/2024
Learn how three companies collaborated to develop and new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.
-
A New Centre For Continuous mRNA Manufacturing
5/14/2024
Explore how a partnership between academia, regulatory agencies, and manufacturing organizations has the potential to reshape the way we produce and distribute mRNA-based therapies.
-
Cell And Virus Banking In OV Development And Manufacturing
5/14/2024
Delve into the exciting potential of OVs, including the critical role of cell and virus seed banks, and discover key considerations for establishing cell and virus banks for OV production.
-
Key Elements Of Process, Analytical Development To Support Tech Transfer
5/13/2024
Tech Transfer for biologic medicinal products is complex - filled with potential pitfalls, hazards, and breakpoints. Review strategies and methodologies for seamless technology transfer to your CDMO.
-
BD Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics
5/9/2024
Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.
-
Avoid Clinical Manufacturing Pitfalls With These Tech Transfer Best Practices
5/8/2024
Ensure a smooth transition from development to manufacturing by implementing a strategic tech transfer process. Review key practices for effective communication, collaboration, and risk mitigation.
-
Selecting An Off-Site GMP Storage Provider
5/8/2024
Understanding how to select a reliable off-site storage provider will empower you to ensure the integrity and accessibility of your valuable biopharmaceutical products, materials, and samples.
-
Key Considerations In Optimizing Downstream Process Development For mAbs
5/8/2024
Optimizing downstream process development for mAbs requires scientific expertise, careful planning, and rigorous testing. Delve into the essential steps and learn how to deliver high-quality mAbs.